DuPont de Nemours, Inc. (DD) Form 8-K — Aug 4, 2026
DuPont reported Q2 2026 results that exceeded guidance, driven by 4% organic sales growth and strong margin expansion across its segments. Adjusted EPS increased 48% year-over-year to $1.88, supported by robust performance in Healthcare & Water Technologies and Diversified Industrials. Transaction-adjusted free cash flow reached $326 million with 127% conversion, reflecting strong operational execution and working capital management. As a result of the outperformance, the company raised its full-year 2026 operating EBITDA guidance midpoint to approximately $1.76 billion and adjusted EPS guidance to $7.24 per share.
Key figures
- Eps
- 1.88
- Revenue
- 1819000000
- Total Debt
- 3125000000
- Revenue Yoy
- 4%
- Cash Position
- 1740000000
- Gaap Eps
- 1.37
- Net Sales
- 1819000000
- Gaap Income
- 191000000
- Operating Ebitda
- 448000000
- Reverse Split Ratio
- 1-for-3
- Share Repurchase Intent
- 250000000
- Transaction Adjusted Free Cash Flow
- 326000000
Price after filing
Close on the filing date to close N calendar days later (from $138.84). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.